4D Molecular Therapeutics, Inc. · NASDAQ:FDMT
4D Molecular Therapeutics, Inc. shareholders
As of Sep 30, 2026, 160 institutions reported holding 4D Molecular Therapeutics, Inc. Largest: Janus Henderson, Ra Capital Management, L.P. and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of 4D Molecular Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Janus Henderson | 5.73M | first report | Nov 16, 2026 | |
| Ra Capital Management, L.P. | 5.05M | no change | Nov 16, 2026 | |
| BlackRock | 4.72M | +179K | Nov 13, 2026 | |
| Goldman Sachs | 3.93M | −328K | Nov 16, 2026 | |
| Vanguard | 3.05M | +80,557 | Nov 13, 2026 | |
| Novo Holdings A/S | 3M | −249K | Nov 16, 2026 | |
| Bvf Inc | 2.88M | no change | Nov 16, 2026 | |
| State Street | 2.47M | −442K | Nov 12, 2026 | |
| T. Rowe Price | 2.32M | −246K | Nov 16, 2026 | |
| Adage Capital Partners Gp, L.L.C. | 2.29M | +40,000 | Nov 16, 2026 |